Skip to main content

Innovative Oral Treatment Options for Patients

When

10/13/20    
6:30 pm - 8:00 pm
Download ICS Google Calendar iCalendar Office 365 Outlook Live

Innovative Oral Treatment Options for Patients: HR+/HER2- mBC or gBRCA-Mutated
Triple-Negative and HR+/HER2- mBC – A virtual Event

 

Presented by:
ANDREW SEIDMAN MD
Attending Physician, Breast Medicine Service
Medical Director, Bobst International Center
Memorial Sloan Kettering Cancer Center
Professor of Medicine, Weill Cornell Medical College

 

Please RSVP to your Pfizer Representative
Dahlia Mann: (310) 422-7978, dahlia.mann@pfizer.com

Kindly provide your full name, degree, specialty, address including state, and email address when registering so that you can be confirmed. Please also reference Meeting ID# INT-0061719

 

Click here for more information.